Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Not yet recruitingOBSERVATIONAL

Enrollment

210

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

April 28, 2026

Conditions

Diffuse Large B Cell LymphomaMultiple Myeloma

Interventions

DIAGNOSTIC_TEST

PointCheck

Binary classification of severe neutropenia

All Listed Sponsors

lead

Leuko Labs, Inc.

INDUSTRY

NCT06323447 - Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia | Biotech Hunter | Biotech Hunter